Table 2 –

patients’ and tumors’ characteristics

Patients (n=22)
			Median (range)
	Age, years		68 (44 – 82)
			n (%)
	Male sex		11 (50%)
	Lymph node involvement		15 (68.2%)
	Metastases		2 (9.1%) *
Tumors (n=23)			n (%)
	Histology	ICC	15 (65.2%)
		PCC and DCC	6 (26.1%)
		Gallbladder cancer	1 (4.3%)
		Mixed HCC-ICC	1 (4.3%)
	SUVmax-bw		5.4 (1.4 – 24.3) **

^*1 peritoneum involvement; 1 liver + peritoneum involvement

^**3 (13%) tumors were not ¹⁸F-FDG-avid

Quantitative data are presented as median and range.

Qualitative data are presented as absolute and relative values.

ICC: intrahepatic cholangiocarcinoma; PCC: perihilar cholangiocarcinoma; DCC: distal cholangiocarcinoma; HCC: hepatocellular carcinoma

SUV_max-bw: maximum standard uptake value body-weighted